Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Integrated digital error suppression for improved detection of circulating tumor DNA.

Newman AM, Lovejoy AF, Klass DM, Kurtz DM, Chabon JJ, Scherer F, Stehr H, Liu CL, Bratman SV, Say C, Zhou L, Carter JN, West RB, Sledge GW, Shrager JB, Loo BW Jr, Neal JW, Wakelee HA, Diehn M, Alizadeh AA.

Nat Biotechnol. 2016 May;34(5):547-555. doi: 10.1038/nbt.3520. Epub 2016 Mar 28.

2.

An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage.

Newman AM, Bratman SV, To J, Wynne JF, Eclov NC, Modlin LA, Liu CL, Neal JW, Wakelee HA, Merritt RE, Shrager JB, Loo BW Jr, Alizadeh AA, Diehn M.

Nat Med. 2014 May;20(5):548-54. doi: 10.1038/nm.3519. Epub 2014 Apr 6.

3.

Potential clinical utility of ultrasensitive circulating tumor DNA detection with CAPP-Seq.

Bratman SV, Newman AM, Alizadeh AA, Diehn M.

Expert Rev Mol Diagn. 2015 Jun;15(6):715-9. doi: 10.1586/14737159.2015.1019476. Epub 2015 Mar 16. Review.

4.

SiNVICT: ultra-sensitive detection of single nucleotide variants and indels in circulating tumour DNA.

Kockan C, Hach F, Sarrafi I, Bell RH, McConeghy B, Beja K, Haegert A, Wyatt AW, Volik SV, Chi KN, Collins CC, Sahinalp SC.

Bioinformatics. 2017 Jan 1;33(1):26-34. doi: 10.1093/bioinformatics/btw536. Epub 2016 Aug 16.

PMID:
27531099
5.

Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA.

Thompson JC, Yee SS, Troxel AB, Savitch SL, Fan R, Balli D, Lieberman DB, Morrissette JD, Evans TL, Bauml J, Aggarwal C, Kosteva JA, Alley E, Ciunci C, Cohen RB, Bagley S, Stonehouse-Lee S, Sherry VE, Gilbert E, Langer C, Vachani A, Carpenter EL.

Clin Cancer Res. 2016 Dec 1;22(23):5772-5782. Epub 2016 Sep 6.

6.

Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients.

Malapelle U, Mayo de-Las-Casas C, Rocco D, Garzon M, Pisapia P, Jordana-Ariza N, Russo M, Sgariglia R, De Luca C, Pepe F, Martinez-Bueno A, Morales-Espinosa D, González-Cao M, Karachaliou N, Viteri Ramirez S, Bellevicine C, Molina-Vila MA, Rosell R, Troncone G.

Br J Cancer. 2017 Mar 14;116(6):802-810. doi: 10.1038/bjc.2017.8. Epub 2017 Feb 7.

7.

Circulating tumour DNA (ctDNA) as a liquid biopsy for melanoma.

Calapre L, Warburton L, Millward M, Ziman M, Gray ES.

Cancer Lett. 2017 Sep 28;404:62-69. doi: 10.1016/j.canlet.2017.06.030. Epub 2017 Jul 4. Review.

8.

The role of ctDNA detection and the potential of the liquid biopsy for breast cancer monitoring.

Openshaw MR, Page K, Fernandez-Garcia D, Guttery D, Shaw JA.

Expert Rev Mol Diagn. 2016 Jul;16(7):751-5. doi: 10.1080/14737159.2016.1184974. Epub 2016 May 17. Review.

PMID:
27144417
9.

Development of a highly sensitive liquid biopsy platform to detect clinically-relevant cancer mutations at low allele fractions in cell-free DNA.

Gale D, Lawson ARJ, Howarth K, Madi M, Durham B, Smalley S, Calaway J, Blais S, Jones G, Clark J, Dimitrov P, Pugh M, Woodhouse S, Epstein M, Fernandez-Gonzalez A, Whale AS, Huggett JF, Foy CA, Jones GM, Raveh-Amit H, Schmitt K, Devonshire A, Green E, Forshew T, Plagnol V, Rosenfeld N.

PLoS One. 2018 Mar 16;13(3):e0194630. doi: 10.1371/journal.pone.0194630. eCollection 2018.

10.

The feasibility of using mutation detection in ctDNA to assess tumor dynamics.

Yi X, Ma J, Guan Y, Chen R, Yang L, Xia X.

Int J Cancer. 2017 Jun 15;140(12):2642-2647. doi: 10.1002/ijc.30620. Epub 2017 Mar 2. Review.

11.

Asymmetrical barcode adapter-assisted recovery of duplicate reads and error correction strategy to detect rare mutations in circulating tumor DNA.

Ahn J, Hwang B, Young Kim H, Jang H, Kim HP, Han SW, Kim TY, Hyun Lee J, Bang D.

Sci Rep. 2017 May 2;7:46678. doi: 10.1038/srep46678.

12.

Biopsy-free circulating tumor DNA assay identifies actionable mutations in lung cancer.

Villaflor V, Won B, Nagy R, Banks K, Lanman RB, Talasaz A, Salgia R.

Oncotarget. 2016 Oct 11;7(41):66880-66891. doi: 10.18632/oncotarget.11801.

13.

Noninvasive diagnosis of actionable mutations by deep sequencing of circulating free DNA in lung cancer from never-smokers: a proof-of-concept study from BioCAST/IFCT-1002.

Couraud S, Vaca-Paniagua F, Villar S, Oliver J, Schuster T, Blanché H, Girard N, Trédaniel J, Guilleminault L, Gervais R, Prim N, Vincent M, Margery J, Larivé S, Foucher P, Duvert B, Vallee M, Le Calvez-Kelm F, McKay J, Missy P, Morin F, Zalcman G, Olivier M, Souquet PJ; BioCAST/IFCT-1002 investigators.

Clin Cancer Res. 2014 Sep 1;20(17):4613-24. doi: 10.1158/1078-0432.CCR-13-3063. Epub 2014 Jul 10.

14.

Assessment of circulating copy number variant detection for cancer screening.

Molparia B, Nichani E, Torkamani A.

PLoS One. 2017 Jul 7;12(7):e0180647. doi: 10.1371/journal.pone.0180647. eCollection 2017.

15.

Methods for Measuring ctDNA in Lymphomas.

Rossi D, Condoluci A, Spina V, Gaidano G.

Methods Mol Biol. 2019;1881:253-265. doi: 10.1007/978-1-4939-8876-1_19.

PMID:
30350211
16.

Cell-free circulating tumour DNA as a liquid biopsy in breast cancer.

De Mattos-Arruda L, Caldas C.

Mol Oncol. 2016 Mar;10(3):464-74. doi: 10.1016/j.molonc.2015.12.001. Epub 2015 Dec 17. Review.

17.

Using circulating cell-free DNA to monitor personalized cancer therapy.

Oellerich M, Schütz E, Beck J, Kanzow P, Plowman PN, Weiss GJ, Walson PD.

Crit Rev Clin Lab Sci. 2017 May;54(3):205-218. doi: 10.1080/10408363.2017.1299683. Epub 2017 Apr 10. Review.

PMID:
28393575
18.

High-throughput sequencing for noninvasive disease detection in hematologic malignancies.

Scherer F, Kurtz DM, Diehn M, Alizadeh AA.

Blood. 2017 Jul 27;130(4):440-452. doi: 10.1182/blood-2017-03-735639. Epub 2017 Jun 9. Review.

19.

Clinical Utility of Circulating Tumor DNA for Molecular Assessment and Precision Medicine in Pancreatic Cancer.

Takai E, Totoki Y, Nakamura H, Kato M, Shibata T, Yachida S.

Adv Exp Med Biol. 2016;924:13-17.

PMID:
27753011
20.

CUT-PCR: CRISPR-mediated, ultrasensitive detection of target DNA using PCR.

Lee SH, Yu J, Hwang GH, Kim S, Kim HS, Ye S, Kim K, Park J, Park DY, Cho YK, Kim JS, Bae S.

Oncogene. 2017 Dec 7;36(49):6823-6829. doi: 10.1038/onc.2017.281. Epub 2017 Aug 28.

Supplemental Content

Support Center